Assessing socio-economic damage caused by coxarthrosis in the population
https://doi.org/10.29413/ABS.2023-8.5.2
Abstract
Background. About 40 % of patients diagnosed with coxarthrosis annually seek medical help and receive social support due to this disease. Increased use of an expensive surgery for treatment of coxarthrosis and projected growth of its prevalence in the population determine the relevance of socio-economic analysis.
The aim of the study. To assess the value and structure of economic damage caused by the delivering health and social care to patients with coxarthrosis at the state level of the Russian Federation.
Methods. To assess economic damage, we used the average annual number of various categories of patients and disabled people with coxarthrosis in the Irkutsk region for 2008–2017. Three main categories were identified: patients who visited the outpatients’ clinic; patients with total hip replacement; disabled people due to coxarthrosis. For each category, we calculated weighted average damage per 1 conventional patient, taking into account direct and indirect costs and subsequent multiplication by the average annual number of individual categories of patients. Calculations were performed in 2017 prices.
Results. The average annual socio-economic damage from coxarthrosis amounted to 1.39 (1.34÷1.43) billion rubles or 0.1 % of the gross regional product. The most of the damage (64.4 %) were indirect costs associated with disability due to coxarthrosis, 22.2 % of the total amount were the costs of hip replacement surgery, 13.4 % were the costs of outpatient visits. Indirect economic losses due to disability in patients of working age were 4.2 times higher than losses due to disability of oldage pensioners.
Conclusion. The results of the study confirm the economic feasibility of surgical treatment of coxarthrosis, especially in patients of working age.
About the Authors
V. A. KoryakRussian Federation
Valentina A. Koryak – Senior Lecturer at the Department of Pathologic Anatomy
Krasnogo Vosstaniya str. 1, Irkutsk 664003
A. D. Botvinkin
Russian Federation
Aleksandr D. Botvinkin – Dr. Sc. (Med.), Professor, Head of the Department of Epidemiology
Krasnogo Vosstaniya str. 1, Irkutsk 664003
V. A. Sorokovikov
Russian Federation
Vladimir A. Sorokovikov – Dr. Sc. (Med.), Professor, Director; Head of the Department of Traumatology, Orthopedy and Neurosurgery
Bortsov Revolyutsii str. 1, Irkutsk 664003;
Yubileyniy 100, Irkutsk 664049
O. M. Chernikova
Russian Federation
Olga M. Chernikova – Head Physician of the Clinic
Bortsov Revolyutsii str. 1, Irkutsk 664003
References
1. Jenkins PJ, Clement ND, Hamilton DF, Gaston P, Patton JT, Howie CR. Predicting the cost-effectiveness of total hip and knee replacement: A health economic analysis. Bone Joint J. 2013; 95- B(1): 115-121. doi: 10.1302/0301-620X.95B1.29835
2. Elmallah RK, Chughtai M, Khlopas A, Bhowmik-Stoker M, Bozic KJ, Kurtz SM, et al. Determining cost-effectiveness of total hip and knee arthroplasty using the short form-6D Utility Measure. J Arthroplasty. 2017; 32(2): 351-354. doi: 10.1016/j.arth.2016.08.006
3. Ekman B, Nero H, Lohmander LS, Dahlberg LE. Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden. PLoS One. 2020; 15(8):e0236342. doi: 10.1371/journal.pone.0236342
4. Lila AM, Karpov OI. Osteoarthrosis: Socio-economic significance and pharmacoeconomic aspects of pathogenetic therapy. Russian Medical Journal. 2003; 28: 1558-1562. (In Russ.).
5. Kuvina VN, Shalina TI, Kuvin SS. Organizational and hygienic aspects of environmentally determined pediatric orthopedic pathology. Siberian Medical Journal. 2009; 8: 179-182. (In Russ.).
6. Savchenkov MF, Efimova NV, Rukavishnikov VS. Problems of regional pathology of the population of Siberia. Siberian Medical Journal. 2011; 7: 141-145. (In Russ.).
7. Dyadik VV, Dyadik NV, Klyuchnikova EM. Economic assessment of environmental effects on public health: A review of methods. Human Ecology. 2021; 2: 57-64. (In Russ.). doi: 10.33396/1728-0869-2021-2-57-64
8. Nwachukwu BU, Bozic KJ, Schairer WW, Bernstein JL, Jevsevar DS, Marx RG, et al. Current status of cost utility analyses in total joint arthroplasty: A systematic review. Clin Orthop Relat Res. 2015; 473(5): 1815-1827. [(In Russ.)]. doi: 10.1007/s11999-014-3964-4
9. Lavernia CJ, Iacobelli DA, Brooks L, Villa JM. The cost-utility of total hip arthroplasty: Earlier intervention, improved economics. J Arthroplasty. 2015; 30(6): 945-949. doi: 10.1016/j.arth.2014.12.028
10. Schlegelmilch M, Rashiq S, Moreau B, Jarrín P, Tran B, Chuck A. Cost-effectiveness analysis of total hip arthroplasty performed by a Canadian short-stay surgical team in Ecuador. Adv Orthop. 2017; 2017: 5109895. doi: 10.1155/2017/5109895
11. Peel TN, Cheng AC, Liew D, Buising KL, Lisik J, Carroll KA, et al. Direct hospital cost determinants following hip and knee arthroplasty. Arthritis Care Res (Hoboken). 2015; 67(6): 782-790. doi: 10.1002/acr.22523
12. Lila AM, Dreval RO, Inamova OV, Shipitsyn VV, Zabotina AN. Medical and economic analysis of the impact of rheumatoid diseaseassociated disability on the country’s economy in terms of implementation of pension reforms. Modern Rheumatology Journal. 2019; 13(4): 18-25. (In Russ.). doi: 10.14412/1996-7012-2019-4-18-25
13. Nasonova VA, Folomeyeva OM, Erdes S. Social importance of rheumatic diseases in Russia. Rheumatology Science and Practice. 2002; 40(1): 5-8. (In Russ.). doi: 10.14412/1995-4484-2002-740
14. Petrunko IL, Menshikova LV, Golubeva PS, Tsyrenzhapova TM. Osteoarthritis: Financial costs per patient. Siberian Medical Journal. 2010; 6: 163-165. (In Russ.).
15. Strumilin SG. On the national economic efficiency of healthcare. Economic Sciences. 1966; 5. (In Russ.).
16. Omelyanovsky VV, Avxentyeva MV, Derkach EV, Sveshnikova ND. Methodological issues of cost of illness analysis. Medical Technologies. Assessment and Choice. 2011; 1: 42-50. (In Russ.).
17. Koryak VA, Botvinkin AD, Sorokovikov VA. Epidemiological assessment of the prevalence of coxarthrosis according to reports from medical organizations. Acta biomedica scientifica. 2022; 7(2): 282-291. (In Russ.). doi: 10.29413/ABS.2022-7.2.28
18. Shakhanina IL, Pimenova MN, Khromenkova VP. Methods for economic assessment of infectious diseases in some foreign countries. Scientific Review of D.I. Mendeleev Institute for Metrology. Moscow; 1977: 125. (In Russ.).
19. Prokhorov BB. Public health and economics. Moscow: MAKS Press; 2007. (In Russ.).
20. Leshchuk SI, Surkova IV, Olshevsky AG. Improved methodology for assessing economic damage from morbidity in the population. Bulletin of Irkutsk State Technical University. 2013; 12(83): 321-326. (In Russ.).
21. Territorial Fund of Compulsory Medical Insurance in the Irkutsk region. Information about the territorial compulsory medical insurance program. (In Russ.). URL: https://www.irkoms.ru/tfoms/cat/sviedieniia-o-tierritorial-noi-proghrammieoms [дата доступа: 15.12.2022].
22. Territorial Body of the Federal State Statistics Service in the Irkutsk region. (In Russ.). URL: https://irkutskstat.gks.ru/folder/45697 [дата доступа: 15.12.2022].
23. Kunkel ST, Sabatino MJ, Kang R, Jevsevar DS, Moschetti WE. The cost-effectiveness of total hip arthroplasty in patients 80 years of age and older. J Arthroplasty. 2018; 33(5): 1359-1367. doi: 10.1016/j.arth.2017.11.063
24. Bitton R. The economic burden of osteoarthritis. Am J Manag Care. 2009; 15(Suppl 8): S230-S235.
25. Nasonova VA. Medical and social significance of the XIII class of ICD diseases for the Russian population. Rheumatology Science and Practice. 2001; 39(1): 7-11. (In Russ.).
Review
For citations:
Koryak V.A., Botvinkin A.D., Sorokovikov V.A., Chernikova O.M. Assessing socio-economic damage caused by coxarthrosis in the population. Acta Biomedica Scientifica. 2023;8(5):14-22. https://doi.org/10.29413/ABS.2023-8.5.2